Diabetic Retinopathy Care and Screening—Is Artificial Intelligence Changing the Future?
Saturday, June 22, at 3:15 p.m. ET
Room W208
Orange County Convention Center
Artificial Intelligence and Novel Retinal Imaging in Diabetic Retinopathy Screening
Aaron Y. Lee, MD, MSCI
Associate Professor,
University of Washington
What is your presentation about?
We are building a publicly available dataset for studying salutogenesis in type 2 diabetes with a multimodal atlas of disease that can be used for countless AI applications. Our initial pilot dataset was recently released at aireadi.org and is meant to vastly accelerate data science for type 2 diabetes research.
How do you hope your presentation will impact diabetes research or care?
I hope that researchers will use this dataset to study heterogeneity and salutogenesis in type 2 diabetes.
How did you become involved with this area of diabetes research or care?
With the NIH Bridge2AI program.